Which of the following has been associated with a mortality benefit in S. aureus bacteremia?
A. Removing the implanted vascular access device (port-a-cath) on the day bacteremia is diagnosed Wrong Choice!
B. Treating S. aureus bacteremia with at least 6 weeks of intravenous antibiotics Wrong Choice!
C. Adding rifampin to intravenous antibiotic therapy Wrong Choice!
D. Infectious diseases consultation Correct Choice
Answer:D
Which of the following has been associated with a mortality benefit in S. aureus bacteremia?
A. Removing the implanted vascular access device (port-a-cath) on the day bacteremia is diagnosed Wrong Choice! B. Treating S. aureus bacteremia with at least 6 weeks of intravenous antibiotics Wrong Choice! C. Adding rifampin to intravenous antibiotic therapy Wrong Choice! D. Infectious diseases consultation Correct Choice